
Overview
Status
Active
Registry date
2023-08-21
Registered address
ul. Nieszawska 19, 61-021 Poznań, Poland
Website
osteonova.euWebsite active
Email
Email inactive
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each director is authorized to make declarations on behalf of the company independently.
Supervisory board
Andrzej Kuprianowicz — Supervisory Board Member & Dyrektor
Wojciech Kapłon — Supervisory Board Member & Dyrektor
Beneficial owners
No beneficial owners recorded for the company Osteonova.
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| DCD Labsp. z o.o. | $3,056,950.70 | dcd-lab.pl | |
| Salon Ortopedyczny Or-Techsp. z o.o. | $453,978.03 | or-tech.pl | |
| Zakład Optyczny Oculussp. z o.o. | $332,546.80 | oculus.com.pl | |
| Gokosp. z o.o. | $229,049.87 | go-ko.pl | |
| PhilabsS.A. | $64,403.10 | phibox.eu | |
| NEO Ortho Pracownia Sztuki Ortopedycznejsp. z o.o. | $5,662.74 | neoortho.pl | |
| Arxam Techsp. z o.o. | $0.00 | arxamtech.pl | |
| Alfa Notionsp. z o.o. | $0.00 | alfanotion.eu | |
| Pinklabsp. z o.o. | — | pinklab.pl | |
| BrasterS.A. | — | braster.eu |
FAQ
The main business activity of Osteonova focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on August 21, 2023.
The headquarters is located at: ul. Nieszawska 19, 61-021 Poznań.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-04-27